NEURONETICS, INC.

Business Segments Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-14 pm EST			5-day change	1st Jan Change
2.160 ^USD	-7.69%		+40.26%	+34.16%

Jan. 13	Neuronetics, Inc. Announces Unaudited Revenue Results for Fourth Quarter and Full Year 2024	CI
Jan. 13	Neuronetics, Inc. Provides Earnings Guidance for the Full Year 2025	CI

Sales 2023 by Business Segment

See more © MarketScreener.com

Sales 2023 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023
Therapeutic Devices
Surgical & Medical Equipment				62.66M	49.24M	55.31M	65.21M	71.35M
Total Assets				100M	78.66M	141M	117M	116M
Interest Expense				-3.68M	-4.52M	-4.02M	-4.25M	-5.42M
CAPEX				-813K	-730K	-2.35M	-3.27M	-2.37M
EBT				-29.04M	-27.45M	-31.19M	-37.16M	-30.19M
Gross Profit				47.27M	37.69M	43.66M	49.72M	51.7M
D&A				1.06M	941K	1.06M	1.65M	2.01M
Operating Income				-26.93M	-22.31M	-27.56M	-35.11M	-30.55M
Net Income				-29.04M	-27.45M	-31.19M	-37.16M	-30.19M

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023
United States				60.76M	47.52M	53.45M	63.41M	69.34M
International				1.9M	1.72M	1.86M	1.8M	2.01M